Unichem Laboratories has completed the sale of 19.97% equity shares in Optimus Drugs (Optimus) to Sekhmet Pharmaventures on September 22, 2022. The company has received payment of around Rs 270.98 crore towards completion of sale of first tranche. For the second tranche, the price to be determined as per the said share purchase agreement after satisfaction of necessary conditions precedent.
Incorporated on December 2, 2003, Optimus is engaged in the business of researching, developing, manufacturing, marketing, and distribution of active pharmaceutical ingredients and intermediates.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: